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We present a retrospective review of the scientiﬁc and clinical advances, extending over four decades, which have linked
vesicoureteral reﬂux, with renal injury, and urinary tract infection. We have traced the original studies, coupled with advances
in technology which led to the awareness, and ability to detect and diagnose the problems early in childhood. These advances
progressed through clinical studies which deﬁned the epidemiology of both reﬂux and urinary tract infection. Along with these
diagnostic advances, there were numerous surgical developments, which allowed progressive improvements in the outcomes and
eﬀectiveness of a variety of treatment modalities. All of this literature leads us to the current era, when several clinical trials are
currently underway in an eﬀort to more fully deﬁne the most eﬃcacious and safe methods to treat vesicoureteral reﬂux and
associated urinary tract infection.
Copyright © 2008 Gordon A. McLorie.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Vesicoureteralreﬂuxmayhavebeenthemajorcatalystforthe
development of the subspecialty of pediatric urology, now
approaching a milestone in North America, with the soon-
to-be awarding of a certiﬁcate of special competence. How
did this happen?
In the ﬁrst textbook of Urology in Childhood, 1974, Dr.
Innes Williams included a chapter on reﬂux, in which his
opening sentence states “the problem of reﬂux has occa-
sioned more controversy than any other topic in pediatric
urology” [1]. I submit in writing this article the view that
this situation has changed very little to this day, more than
30 years later.
Reﬂux was recognized very early, as an abnormal func-
tion of the ureterovesical junction, but it was Hutch who
recognized it in association with neurogenic bladder, in the
spinal injured patients, and who linked the reﬂux to the
renal injury in those patients [2]. Reﬂux was subsequently
demonstrated in some pediatric patients with UTI, but there
wereseveralstudieswhichshowedthatreﬂuxwasnotpresent
in normal infants. These data were brought forward because
of the ready availability of voiding cystourethrography—we
now assume that these studies are routine and customary—
whereas in 1960s and 1970s they were neither available
technically, nor did many imagers have any of the facilities
or skills that are now standard of care throughout the world.
The next milestone was the recognition that vesi-
coureteralreﬂux wasassociated withurinary tractinfections,
but also that it occurred as a primary defect in children.
Prior principles had shown reﬂux to be associated with other
congenital anomalies or defects such as neurogenic bladder.
Hodson and Edwards [3] described a relationship between
urinary tract infections and reﬂux, and further investigators
demonstrated this to be present in a signiﬁcant number of
children with recurrent pyelonephritis [4]. These ﬁndings
led physicians and surgeons to recognize the importance of
UTI as a cause of both pyelonephritis and as an extension of
this to recognize relationship between chronic scarring and
end-stage renal disease, and UTI with reﬂux. Kunin (1970)
published data showing the prevalence of UTI in school-
age children. The scene was set for the imposition of two
forms of therapy which emerged as the science of the day—
antibioticsforgramnegativebacterialinfections,andsurgery
for vesicoureteral reﬂux.
The 1970s witnessed the emergence of antibiotics,
including aminioglycosides, chloramphenicol, and cephalo-
sporins, which proved eﬀective in the treatment of sepsis
and pyelonephritis caused by gram negative organisms.
Although one of these proved myelotoxic and was removed
from use, the others continued to be employed more
frequently, and further reﬁnements both improved their2 Advances in Urology
eﬃcacy and reduced their toxicity. Along with the readily
available treatment modalities, the recognition of UTI as
an important cause of sepsis in the neonate and young
infant became a more common diagnosis. In this era, the
diﬀerential diagnosis fever in an infant included meningitis
which was much more common as a cause of fever and
sepsis in infants’ than is now the case. Thus, the subsequent
investigation of UTI, with personnel and equipment to
carry out eﬀective cystograms, led to the diagnosis of
vesicoureteral reﬂux in increasing numbers. Parallel with
the growing frequency of the diagnosis of reﬂux was a
growing experience and expertise in the surgery of reﬂux.
Politano and Leadbetter [5]d e s c r i b e da ne ﬀective operative
procedure which could achieve successful treatment with
relatively minimal morbidity—this became widely utilized
in North America, while the Lich Gregoir extravesical
techniques [6] were more widely used in Europe. Following
upon these successes, Paquin [7], Glenn and Anderson [8],
and ﬁnally Cohen [9] improvements and modiﬁcations of
ureteroneocystostomy are resulting in their wide utilization
throughout the world in 1980s. The AAP section of urology
was started in this period, and the specialty of pediatric
urology emerged as a recognized specialty, dedicated to
the treatment of children with congenital defects of the
genitourinary system.
Dr. John Duckett and a dedicated group of colleagues
bridged the gap between pediatric urologists and pediatric
nephrologists, in both Europe and North America, to
formulate a prospective study to test the hypothesis of the
best treatment for vesicoureteral reﬂux. The international
reﬂux study was born and completed, with publications in
1992, which answered some questions, but left many more
unanswered.Itwasapparentthatsurgicalcorrectionofreﬂux
was feasible, safe, although inconsistent in the complication
rates at varying centers. Similarly, it was apparent that
reﬂux would resolve spontaneously. Thus, the most optimal
treatment was uncertain. The outcomes measured were
primarily renal scarring, but other features of the “disease”
becamemoreconfusing—wastherenalscarringpre-existent,
or solely the result of the reﬂux, or of the UTI? Although
dysfunctional voiding was an exclusion factor, the study
concluded that 15% of children did have dysfunctional
voiding. Was this now to play a part in the treatment of the
recurring UTIs? Was the reﬂux actually a factor in the UTIs,
since even after the correction of reﬂux, persistence of UTIs
occurred? Many questions were answered, but many more
remained.
In this era of excitement and involvement in the inter-
national reﬂux study, a new player emerged as O’Donnell
a n dP u r i[ 10] published data in 1984, showing that the
cystoscopic injection of Teﬂon paste into the subureteric
space could result in the resolution of vesicoureteral reﬂux.
Following the rapid popularization of this technique, mainly
in Europe, it was disclosed by researchers in USA [11] that
Teﬂon could potentially be absorbed, and migrate to other
areas of the body, including the brain and lymphatics. These
data, combined with speculation and fear that leaked Teﬂon,
leaked from prosthetic implants could be a potential cause of
autoimmune disease, led the Federal authorities in USA to
insure that the subureteric injection of Teﬂon would not be
approved in North America. Nonetheless, a new debate had
been born, centered on the child with UTI and vesicoureteral
reﬂux. At meetings, becoming more populated with well
trained and proﬁcient pediatric urologists from around the
world, debates became heated, stimulating, and amusing.
Three of our greatest leaders, each a proponent of either
open surgical correction, observational treatment alone or
subureteric injection (Duckett, Ransley, O’Donnell), led the
assemblies in ever increasing circles of confusion and varied
convictions.
Two new pieces of data were added to the continu-
ing puzzle; the emergence of antenatal ultrasound, which
showed hydronephrosis in up to 1% of fetuses, and the
publication by Noe [12], that vesicoureteral reﬂux could be
shown in up to 25% of siblings who were diagnosed with
reﬂux. The groups of children with reﬂux diagnosed on the
basis of either antenatal hydronephrosis and subsequently
diagnosed reﬂux (20% of those with hydronephrosis), and
also those diagnosed on the basis of sibling screening led to
an ever increasing population of children with reﬂux.
Perhaps the latest piece of the technology puzzle, was
addedbyL¨ ackgrenetal.,whopublisheddataonanewersub-
stance, dextranomer/hyaluronic acid copolymer (Dx/HA)
[13], which unlike other alternates to Teﬂon, proved to be
durable, eﬀective, and safe. It was approved for use in the
USA and Canada and is now widely utilized around the
world.
Antibiotic prophylaxis, the nonsurgical treatment
modality used throughout all these decades as an alternate
to surgical therapy, has now also come into dispute. The
emergence of resistant strains of gram negative bacteria
is growing, and possibly based on the widespread generic
use of many antibiotics, a global increase in methicillin
resistant staph aureus (MRSA) is posing serious challenges
to treatment of infants with sepsis.
A new multicenter trial is now opened for recruitment
in the United States and Canada (RIVUR), funded by
the NIDDK, which will randomize children, presenting
with UTI, and reﬂux between treatment with prophylactic
antibiotics, and with observation alone [14]. The primary
end point is the recurrence of UTI, with secondary end
point being the development of renal scar. A similar study
is ongoing in France.
We have come full circle, starting with a new diagnosis—
reﬂux, previously unrecognized, which was assumed to be
a cause of recurrent uti, and renal scarring, through three
decades of evolving developments in technology and science
showing a myriad of ways in which we could cure the reﬂux.
Over 25 years ago, Dr. JR Woodard, a world leader of the
time, stated “As one looks back over the last 30 years of reﬂux
history, it is ironic that urologists have become so expert
at its surgical correction before understanding much about
its natural history and true clinical signiﬁcance” [15]. We
now dwell in a world where we STILL question whether the
reﬂux itself is the major problem, or just an easily diagnosed
and treated cofactor. Hopefully, the rigors of current science,
basedonprospectiveandrandomizeddata,willanswersome
of these ongoing questions and allow us to treat the children,Gordon A. McLorie 3
whom we treat, with the best, safest, most cost-eﬀective, and
noninvasive methodologies available to achieve our health-
related aims. I believe these aims continue to be the eﬀective
treatment and prevention of UTI and the prevention of renal
injury.
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